ATGAM

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1979-2018
051019792018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND Use of induction for renal transplantation is controversial because of the concerns about long-term safety and… (More)
Is this relevant?
2005
2005
BACKGROUND Induction immunosuppressive therapy with the anti-T-cell antibody Thymoglobulin decreases the incidence of acute… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Two patients with end-stage renal disease secondary to multiple myelomas were treated with combined kidney and bone… (More)
Is this relevant?
2000
2000
OBJECTIVE To evaluate the economic implications for transplant centres, Medicare and society of treatment of corticosteroid… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND The aim of this study was to compare the efficacy and safety of Thymoglobulin (a rabbit-derived polyclonal antibody… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Thymoglobulin, a rabbit anti-human thymocyte globulin, was compared with Atgam, a horse anti-human thymocyte globulin… (More)
Is this relevant?
1996
1996
Polyclonal antibodies, used for both induction and rejection therapy in renal transplant recipients, are associated with such… (More)
Is this relevant?
1995
1995
Exposure to the equine-derived polyclonal antithymocyte preparation, ATGAM, frequently elicits human anti-ATGAM antibody… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Mycophenolate mofetil (MMF), a new immunosuppressant that selectively inhibits proliferation of T and B lymphocytes, may reduce… (More)
Is this relevant?
1979
1979
Twenty renal allograft recipients were treated with antithymocyte globulin (ATGAM; ATG) for up to 16 weeks in addition to… (More)
Is this relevant?